CVE-2021-44092

Exploitation

Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.

SSVC decision

Not assessed by CISA

EPSS probability

1.25% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 67.4% of scored records. A rank, not a probability.

NVD base score

9.8 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2022-01-20 18:03Z4 YR AGO

Last updated

2024-08-04 04:10Z2 YR AGO

Reserved

2021-11-22

Assigning CNA

mitre

Record state

PUBLISHED

Severity

Not rated by the issuing CNA

CNA CVSS vector

Not published by the issuing CNA

Weaknesses

• CWE-89Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection')Base

Data version

5.1

Document digest

124e44d5c816a8ae432c85206317c5171d2f6feb75c8a1deb675151d5d20130b

• github.comhttps://github.com/nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/code-projects/Pharmacy-Managementx_refsource_MISC